Size of Myocardial Infarction may be Reduced by a Novel Treatment Approach

by Kathy Jones on  March 2, 2014 at 12:40 PM Heart Disease News
RSS Email Print This Page Comment bookmark
Font : A-A+

A novel treatment for myocardial infarction has been developed by researchers at the University of Eastern Finland (UEF).
 Size of Myocardial Infarction may be Reduced by a Novel Treatment Approach
Size of Myocardial Infarction may be Reduced by a Novel Treatment Approach

In a study carried out at the UEF, virus vectors were used in a mouse model to deliver small RNA molecules into the heart, and this significantly reduced the size of myocardial infarction. In the novel treatment method, RNA molecules are targeted at the regulatory area of the vascular endothelial growth factor gene (VEGF-A). These molecules use epigenetic mechanisms to enhance the production of the growth factor in cells.

The study also focused on the mechanisms of this new treatment, epigenetherapy, in cell models. The study was carried out in collaboration between researchers of the MRI Research Group at the A.I. Virtanen Institute for Molecular Sciences at the UEF, the University of Jyväskylä, and Temple University in Philadelphia. The study was published in PLOS ONE on 26 February.



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Cardiac Markers Cardiogenic Shock 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...